|
| | Publication Year | Title | Author(s) |
| 21 | 31-Oct-2020 | BCL-XL is an actionable target for treatment of malignant pleural mesothelioma. | Arulananda, Surein; O'Brien, Megan; Evangelista, Marco; Harris, Tiffany J ; Steinohrt, Nikita S; Jenkins, Laura J; Walkiewicz, Marzena; O'Donoghue, Robert J J; Poh, Ashleigh R; Thapa, Bibhusal ; Williams, David S ; Leong, Trishe; Mariadason, John M ; Li, Xia; Cebon, Jonathan S ; Lee, Erinna F; John, Thomas ; Fairlie, Walter Douglas |
| 22 | Aug-2020 | Molecular regulators of lipid metabolism in the intestine - Underestimated therapeutic targets for obesity? | Dávalos-Salas, Mercedes; Mariadason, John M ; Watt, Matthew J; Montgomery, Magdalene K |
| 23 | 21-Apr-2020 | Prostate cancer cell-intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone. | Owen, Katie L; Gearing, Linden J; Zanker, Damien J; Brockwell, Natasha K; Khoo, Weng Hua; Roden, Daniel L; Cmero, Marek; Mangiola, Stefano; Hong, Matthew K; Spurling, Alex J; McDonald, Michelle; Chan, Chia-Ling; Pasam, Anupama; Lyons, Ruth J; Duivenvoorden, Hendrika M; Ryan, Andrew; Butler, Lisa M; Mariadason, John M ; Giang Phan, Tri; Hayes, Vanessa M; Sandhu, Shahneen; Swarbrick, Alexander; Corcoran, Niall M; Hertzog, Paul J; Croucher, Peter I; Hovens, Chris; Parker, Belinda S |
| 24 | Mar-2020 | Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer. | Williams, David S ; Mouradov, Dmitri; Browne, Clare; Palmieri, Michelle; Elliott, Meg J; Nightingale, Rebecca; Fang, Catherine G; Li, Rita; Mariadason, John M ; Faragher, Ian; Jones, Ian T; Churilov, Leonid ; Tebbutt, Niall C ; Gibbs, Peter; Sieber, Oliver M |
| 25 | 22-Nov-2019 | Genomic Profiling of Biliary Tract Cancer Cell Lines Reveals Molecular Subtypes and Actionable Drug Targets. | Lau, David K ; Mouradov, Dmitri; Wasenang, Wiphawan; Luk, Ian Y; Scott, Cameron M; Williams, David S ; Yeung, Yvonne H ; Limpaiboon, Temduang; Iatropoulos, George F ; Jenkins, Laura J; Reehorst, Camilla M; Chionh, Fiona; Nikfarjam, Mehrdad ; Croagh, Daniel; Dhillon, Amardeep S; Weickhardt, Andrew J ; Muramatsu, Toshihide; Saito, Yoshimasa; Tebbutt, Niall C ; Sieber, Oliver M; Mariadason, John M |
| 26 | 22-Nov-2019 | Deletion of intestinal Hdac3 remodels the lipidome of enterocytes and protects mice from diet-induced obesity. | Dávalos-Salas, Mercedes; Montgomery, Magdalene K; Reehorst, Camilla M; Nightingale, Rebecca; Ng, Irvin; Anderton, Holly; Al-Obaidi, Sheren; Lesmana, Analia; Scott, Cameron M; Ioannidis, Paul; Kalra, Hina; Keerthikumar, Shivakumar; Tögel, Lars; Rigopoulos, Angela; Gong, Sylvia J; Williams, David S ; Yoganantharaja, Prusoth; Bell-Anderson, Kim; Mathivanan, Suresh; Gibert, Yann; Hiebert, Scott; Scott, Andrew M ; Watt, Matthew J; Mariadason, John M |
| 27 | 17-Sep-2019 | Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin. | Rao, Devika; Mallick, Atrayee Basu; Augustine, Titto; Daroqui, Cecilia; Jiffry, Jeeshan; Merla, Amartej; Chaudhary, Imran; Seetharam, Raviraja; Sood, Arjun; Gajavelli, Srikanth; Aparo, Santiago; Rajdev, Lakshmi; Kaubisch, Andreas; Chuy, Jennifer; Negassa, Abdissa; Mariadason, John M ; Maitra, Radhashree; Goel, Sanjay |
| 28 | 24-Apr-2019 | BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival. | Lee, Erinna F; Harris, Tiffany J ; Tran, Sharon; Evangelista, Marco; Arulananda, Surein; John, Thomas ; Ramnac, Celeste; Hobbs, Chloe; Zhu, Haoran; Gunasingh, Gency; Segal, David; Behren, Andreas; Cebon, Jonathan S ; Dobrovic, Alexander ; Mariadason, John M ; Strasser, Andreas; Rohrbeck, Leona; Haass, Nikolas K; Herold, Marco J; Fairlie, W Douglas |
| 29 | 17-Dec-2018 | Enhanced Solubility, Permeability and Anticancer Activity of Vorinostat Using Tailored Mesoporous Silica Nanoparticles. | Meka, Anand Kumar; Jenkins, Laura J; Dàvalos-Salas, Mercedes; Pujara, Naisarg; Wong, Kuan Yau; Kumeria, Tushar; Mariadason, John M ; Popat, Amirali |
| 30 | 1-Nov-2018 | The prognostic impact of Consensus Molecular Subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial. | Mooi, Jennifer K ; Wirapati, P; Asher, R; Lee, C K; Savas, P S; Price, T J; Townsend, A; Hardingham, J; Buchanan, D; Williams, D ; Tejpar, S; Mariadason, John M ; Tebbutt, Niall C |
| 31 | 30-Aug-2018 | ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer. | Luk, Ian Y; Reehorst, Camilla M; Mariadason, John M |
| 32 | Apr-2018 | Interleukin 33 Signaling Restrains Sporadic Colon Cancer in an Interferon-γ-Dependent Manner. | Eissmann, Moritz F ; Dijkstra, Christine ; Wouters, Merridee A; Baloyan, David; Mouradov, Dmitri; Nguyen, Paul M; Davalos-Salas, Mercedes; Putoczki, Tracy L; Sieber, Oliver M; Mariadason, John M ; Ernst, Matthias ; Masson, Frederic |
| 33 | Apr-2018 | Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol Study. | Lau, David K ; Tay, Rebecca Y; Yeung, Yvonne H ; Chionh, Fiona; Mooi, Jennifer; Murone, Carmel ; Skrinos, Effie; Price, Timothy J; Mariadason, John M ; Tebbutt, Niall C |
| 34 | 29-Jan-2018 | DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis. | Tögel, Lars; Nightingale, Rebecca; Wu, Rui; Chüeh, Anderly C; Al-Obaidi, Sheren; Luk, Ian; Dávalos-Salas, Mercedes; Chionh, Fiona; Murone, Carmel ; Buchanan, Daniel D; Chatterton, Zac; Sieber, Oliver M; Arango, Diego; Tebbutt, Niall C ; Williams, David; Dhillon, Amardeep S; Mariadason, John M |
| 35 | Jan-2018 | Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer. | Dopeso, Higinio; Rodrigues, Paulo; Bilic, Josipa; Bazzocco, Sarah; Cartón-García, Fernando; Macaya, Irati; de Marcondes, Priscila Guimarães; Anguita, Estefanía; Masanas, Marc; Jiménez-Flores, Lizbeth M; Martínez-Barriocanal, Águeda; Nieto, Rocío; Segura, Miguel F; Schwartz, Simo; Mariadason, John M ; Arango, Diego |
| 36 | 2018 | Cell Line Models of Molecular Subtypes of Colorectal Cancer. | Mooi, Jennifer K ; Luk, Ian Y; Mariadason, John M |
| 37 | Oct-2017 | Aberrant DNA Methylation in Colorectal Cancer: What Should We Target? | Tse, Janson W T; Jenkins, Laura J; Chionh, Fiona; Mariadason, John M |
| 38 | 26-Sep-2017 | Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer. | Chüeh, Anderly C; Liew, Mun-Sem; Russell, Prudence A; Walkiewicz, Marzena; Jayachandran, Aparna; Starmans, Maud H W; Boutros, Paul C; Wright, Gavin; Barnett, Stephen A ; Mariadason, John M ; John, Thomas |
| 19 | 15-Sep-2017 | ATF3 Repression of BCL-XL Determines Apoptotic Sensitivity to HDAC Inhibitors across Tumor Types. | Chüeh, Anderly C; Tse, Janson W T; Dickinson, Michael; Ioannidis, Paul; Jenkins, Laura; Togel, Lars; Tan, BeeShin; Luk, Ian; Davalos-Salas, Mercedes; Nightingale, Rebecca; Thompson, Matthew R; Williams, Bryan R G; Lessene, Guillaume; Lee, Erinna F; Fairlie, Walter D; Dhillon, Amardeep S; Mariadason, John M |
| 20 | Sep-2017 | K-Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines. | Yeung, Yvonne; Lau, David K ; Chionh, Fiona; Tran, Hoanh; Tse, Janson W T; Weickhardt, Andrew J ; Nikfarjam, Mehrdad ; Scott, Andrew M ; Tebbutt, Niall C ; Mariadason, John M |
Loading...
2
0
20
0
false
0000-0001-9123-7684